During the past decade, Epic Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epic Care" #1 collaborator was "Gynecologic Oncology Group" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Epic Care" are "Advanced Breast Cancer" (1 trials), "CML" (1 trials), "Carcinoma, Ovarian Epithelial" (1 trials), "Fallopian Tube Adenocarcinoma" (1 trials) and "Fallopian Tube Neoplasms" (1 trials). Many other conditions were trialed in "Epic Care" in a lesser frequency.

Most popular intervention types in "Epic Care" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Oregovomab" (1 trials), "Paclitaxel" (1 trials), "Placebo" (1 trials) and "nilotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epic Care" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Epic Care". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Epic Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Epic Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".